Experimental Evolution of Pathogenic <i>Candida</i> spp.: Insights into Adaptive Processes and Evolutionary Dynamics. [PDF]
Sousa G, Correia I, Bezerra AR.
europepmc +1 more source
Urosepsis by multidrug-resistant <i>Nakaseomyces glabratus</i> with non-functional Erg3 and Erg11-do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal? [PDF]
Carolus H +14 more
europepmc +1 more source
Impact of <i>Candida albicans NDT80</i> and <i>UME6</i> on biofilm formation and fluconazole susceptibility. [PDF]
Goerlich K, Mitchell AP.
europepmc +1 more source
The Silent Pandemic: Antifungal Resistance and the Future of Invasive Fungal Disease Management. [PDF]
Bagga R, Kavanoor Sridhar K.
europepmc +1 more source
Severe Pulmonary Coccidioidomycosis Treated With Systemic Corticosteroids in an Adolescent Child. [PDF]
Shinozaki R +3 more
europepmc +1 more source
In vitro antifungal resistance and molecular analysis of the SQLE gene in dermatophytosis: a laboratory-based study. [PDF]
Charlies J +3 more
europepmc +1 more source
Natural product based approaches to overcome <i>Candida glabrata</i> and emerging AMR threats. [PDF]
Sahu BK, Patra SK, Sahu MC, Panda SK.
europepmc +1 more source
Coccidioidomycosis in Thailand: a diagnostic challenge in a non-endemic country. [PDF]
Leelabooranasak C +5 more
europepmc +1 more source
Exploitation of actinomycetes from coastal ecosystems of İzmir Peninsula for antimicrobial activity via strain identification, untargeted metabolomics and drug combination studies. [PDF]
Kurt MÜ +6 more
europepmc +1 more source
Experimental evolution of fungal pathogens as a tool to unravel host adaptation and virulence. [PDF]
Jansen PM, Hube B, Brunke S.
europepmc +1 more source

